Bioavailability & Bioequivalence Studies:

Companies conduct bioavailability studies both at the beginning of human testing and just prior to marketing to show that the formulation used to demonstrate safety and efficacy in clinical trials is equivalent to the product that will be distributed for sale.

Companies also conduct bioavailability studies on marketed products whenever they change the method used to administer the drug (e.g., from injection or oral dose form), the composition of the drug, the concentration of the active ingredient, or the manufacturing process used to produce the drug.

A team of senior pharmacist & chemists is behind the Repharm Services for conducting Bioavailability & Bioequvelence Studies. The team members have also completed Bioavaliability studies and 1 Bioequvelence Studies for national companies. Some of these are as follows;